Physician profile
Chelsea Hendricks
NPI 1083104319
$3,323.73
in general payments reported to CMS, 2019-2025
17 companies · $362 in 2025
The $362 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $600 · 2020: $796 · 2021: $495 · 2022: $320 · 2023: $584 · 2024: $166 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,111.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $675.99 | 2020-2021 | |
| Stryker Corporation | $508.81 | 2022-2025 | Citrefix, Prophecy, Easyfuse |
| Osteomed LLC | $359.61 | 2020-2022 | |
| Paragon 28, INC. | $228.82 | 2020-2024 | Grappler |
| Zimmer Biomet Holdings, INC. | $194.31 | 2019-2020 | |
| Horizon Therapeutics Plc | $181.87 | 2019-2022 | |
| Depuy Synthes Sales INC. | $157.63 | 2019-2020 | |
| Smith+Nephew, INC. | $156.40 | 2023-2025 | Stravix Pl, Renasys Go V2 Home, Collagenase Santyl |
| Saxum Surgical, INC. | $151.91 | 2023-2025 | |
| Integra Lifesciences Corporation | $150.45 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Pacira Pharmaceuticals Incorporated | $102.41 | 2019 | |
| Averitas Pharma INC. | $100.36 | 2023 | Qutenza |
| Cardiovascular Systems INC. | $100.17 | 2019-2021 | |
| Medline Industries LP | $97.07 | 2022 | |
| Organogenesis INC. | $74.95 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $68.93 | 2019 | |
| Treace Medical Concepts, INC. | $14.04 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chelsea Hendricks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.